Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.

Abstract excerpt

For many drugs, pharmacogenetic polymorphisms are known affecting biotransformation and clinical outcome. The clinical importance of these variants depends on allele-frequency and the effect size of the clinical outcome parameters. Further, it depends on the therapeutic range of the drug which is affected, on predictability of drug response as well as on duration until onset of therapeutic efficacy. Consequences...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antidepressive Agents
• Share to Aryl Hydrocarbon Hydroxylases
• Share to Cytochrome P-450 CYP2C9